Disseminated Large B Cell Lymphoma clinical trials

Explore recruiting disseminated large b cell lymphoma clinical trials.

Also recruiting in Europe

Disseminated Large B Cell Lymphoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SAKK 38/19: Assessing a ctDNA and PET-oriented therapy in patients with DLBCL. A multicenter, open-label, phase II trial

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Disseminated Large B Cell Lymphoma trials by city

Disseminated Large B Cell Lymphoma in Toronto Disseminated Large B Cell Lymphoma in Vancouver Disseminated Large B Cell Lymphoma in Montreal Disseminated Large B Cell Lymphoma in Calgary Disseminated Large B Cell Lymphoma in Edmonton Disseminated Large B Cell Lymphoma in Ottawa Disseminated Large B Cell Lymphoma in Winnipeg Disseminated Large B Cell Lymphoma in Quebec City Disseminated Large B Cell Lymphoma in Hamilton Disseminated Large B Cell Lymphoma in Kitchener Disseminated Large B Cell Lymphoma in London Disseminated Large B Cell Lymphoma in Halifax Disseminated Large B Cell Lymphoma in New York Disseminated Large B Cell Lymphoma in Los Angeles Disseminated Large B Cell Lymphoma in Chicago Disseminated Large B Cell Lymphoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease